Please enable JavaScript.
Coggle requires JavaScript to display documents.
Warfarin (Raised INR (Major bleeding (Stop warfarin (Vit K IV (Onset of…
Warfarin
Raised INR
Major bleeding
Stop warfarin
Vit K IV
-
- Oral is as efficacious as IV
- Oral Vit K can → prolonged anticoagulant resistance
- If continuing anticoagulation, avoid if possible
-
-
8 (no bleed or minor bleeding)
Stop warfarin and restart when INR <5
Vit K IV/PO if risk factors for bleeding
E.g. head injury, stroke, epistaxis, prev Hx
-
-
-
-
Indications
NB. Pts. w/ Ca-assoc. VTE should initially be treated for 6mo with therapeutic dose of LMWH rather than warfarin
-
Prophylaxis
- VTE
- AF
- Mechanical heart valves
- Large anterior MI (for 3mo)
- Dilated cardiomyopathy / LV aneurysm
-
Side Effects
Haemorrhage, bruising
Skin necrosis (due to protein S deficiency)
Purple toe syndrome (cholesterol embolism)
Osteoporosis
Hepatic dysfunction
-
MOA
-Inhibits Vit K epoxide reductase
- Prevents recycling of Vit K → functional Vit K deficiency
- Inhibits synthesis of factors 2, 7, 9, 10, C and S
- Initially procoagulant: protein S is depleted first.
Pharmacokinetics
- Long t½: 40hrs
- Takes 16hrs to affect INR
- Peak INR effect of a dose seen @ 2-3d
- Effect of a given dose lasts 4-5d
- Highly albumin-bound
-
-
- Continuing warfarin: 0.5mg slow IV
- Discontinuing warfarin: 2.5-5mg IV